- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharma
Momenta Pharmaceuticals Inc+ Add to Watchlist
MNTA:US15.1800 USD 0.1100 0.73%
As of 20:10:00 ET on 03/30/2015.
Company Profile for Momenta Pharmaceuticals Inc (MNTA)
Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.
Momenta Pharmaceuticals Inc
Key Executives for Momenta Pharmaceuticals Inc (MNTA)
|Craig A WheelerPresident/CEO||Michael FrankenPres:Biosimilars Business/Senior VP|
|Richard P Shea "Rick"Senior VP/CFO||Bruce A LeicherSenior VP/Secy/General Cnsl|
|James M RoachSenior VP:Development/CMO||Ganesh Venkataraman KaundinyaSenior VP:Research/CSO|
|John E BishopSenior VP:Pharmaceutical||Lora L PikeSenior Dir:Investor Relations|